By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sandoz, Inc. 

506 Carnegie Center Drive, Suite 400

Princeton  New Jersey  08540  U.S.A.
Phone: 609-627-8500 Fax: 609-627-8683




Company News
Novartis AG (NVS) Release: FDA Approves First Biosimilar Zarxi (Filgrastim-Sndz) From Sandoz, Inc. 3/6/2015 7:46:53 AM
Novartis AG (NVS)'s Sandoz Bags Approval for First Biosimilar to be Sold in the U.S. 3/6/2015 7:44:03 AM
Phase 3 Data Shows Sandoz, Inc.'s Investigational Biosimilar Filgrastim Has Similar Safety And Efficacy As Amgen (AMGN)'s NEUPOGEN┬« 12/8/2014 6:03:23 AM
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Belgium By Sandoz, Inc. 11/3/2014 8:53:35 AM
Amgen (AMGN), Sandoz, Inc. Biosimilar War Could Provide Playbook, Says Analyst 10/30/2014 2:02:08 PM
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Sweden By Sandoz, Inc. 8/4/2014 8:18:49 AM
Anacor Pharmaceuticals, Inc. (ANAC) Inks Exclusive Deal With Sandoz, Inc. For Kerydin; Anacor To Receive Upfront $40 Million 7/21/2014 8:07:24 AM
Sandoz, Inc. Stays In New Jersey, Moves To Former Home Of Novo Nordisk A/S (NVO) 7/10/2014 7:49:47 AM
Acura Pharmaceuticals, Inc. (ACUR) Announces Settlement Of Patent Litigation With Sandoz, Inc. 5/22/2014 8:55:23 AM
Novartis AG (NVS) Names New Heads Of Alcon, Inc. (ACL), Sandoz, Inc. Units 4/9/2014 6:19:43 AM